Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Director's Dealing

10 Apr 2013 15:07

VERONA PHARMA PLC - Director's Dealing

VERONA PHARMA PLC - Director's Dealing

PR Newswire

London, April 10

Director's Dealing

10 April 2013 - London, UK - Verona Pharma plc (AIM: VRP.L) (the "Company") hasreceived notification that on 10 April 2013, Jan-Anders Karlsson, CEO and adirector of the Company, acquired 150,000 ordinary shares of 0.1p each in theCompany ("Ordinary Shares") at a price of 2.48 pence per share.

As a result, Dr. Karlsson is interested in 800,000 Ordinary Shares,representing approximately 0.1% of the Company's issued ordinary share capital.

-Ends-

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300 Jan-Anders Karlsson, CEO info@veronapharma.com WH Ireland Limited Tel: 020 7220 1650 Chris Fielding chris.fielding@wh-ireland.co.uk

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS